Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001019056-03-000213
Filing Date
2003-03-06
Accepted
2003-03-06 15:45:42
Documents
12
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K covance_10k02.htm 10-K 565199
3 GRAPHIC eysignature.jpg GRAPHIC 3659
4 GRAPHIC pwcsignature.jpg GRAPHIC 3626
5 EXHIBIT 10.8 ex10_8.txt EX-10 37181
6 EXHIBIT 10.36 ex10_36.txt EX-10 34030
7 EXHIBIT 10.37 ex10_37.txt EX-10 31693
8 EXHIBIT 10.38 ex10_38.txt EX-10 18700
9 EXHIBIT 10.39 ex10_39.txt EX-10 23861
10 EXHIBIT 23.1 ex23_1.txt EX-23 2155
11 EXHIBIT 23.2 ex23_2.txt EX-23 704
12 EXHIBIT 99.1 ex99_1.txt EX-99 1483
13 EXHIBIT 99.2 ex99_2.txt EX-99 1582
  Complete submission text file 0001019056-03-000213.txt   726729
Mailing Address CORNING PHARMACEUTICAL SERVICES INC 210 CARNEGIE CENTER PRINCETON NJ 08540
Business Address 210 CARNEGIE CENTER PRINCETON NJ 08540 6094524440
COVANCE INC (Filer) CIK: 0001023131 (see all company filings)

EIN.: 223265977 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12213 | Film No.: 03594682
SIC: 8731 Services-Commercial Physical & Biological Research